Search for: "Bristol Myers Squibb"
Results 601 - 620
of 866
Sort by Relevance
|
Sort by Date
20 Jan 2011, 12:50 pm
Bristol-Myers Squibb Co., 353 F.3d 848, 852 (10th Cir. 2003); In re Norplant Contraceptive Products Liability Litigation, 955 F. [read post]
16 Dec 2010, 1:54 pm
We would all go down together!! [read post]
10 Dec 2010, 3:06 am
., 2000 US Dist LEXIS 21316, *12-13 [2000]; Grant v Bristol-Myers Squibb, 97 F Supp 2d 986, 992 [2000]). [read post]
6 Dec 2010, 12:43 pm
According to a recent article in the Wall Street Journal (WSJ), pharmacy companies such as Merck, Pfizer, Bristol-Myers Squibb, and Eli Lilly, paid a total of over $6 billion in settlements for federal whistleblower-initiated cases between 2001 and 2009. [read post]
30 Nov 2010, 12:30 pm
In this case, Jeffery Bethune, a former pharmaceutical representative filed a lawsuit against the Bristol-Myers Squibb Company alleging that the company illegally denied him overtime pay for hours he worked over forty. [read post]
30 Nov 2010, 8:57 am
Prior to working for Bill Gates, she worked for a variety of companies including Bristol-Myers Squibb Company, PepsiCo, Inc., Enron Corporation, pcOrder.com, Inc., and Trilogy Inc. [read post]
24 Nov 2010, 12:37 am
Use of pipeline system (IP tango) EU: Notes from EU Parliament meeting on innovation+access for medical technologies (KEI) Netherlands: District Court of The Hague declares Dutch part of Bayer’s European patent covering anti-TNF alpha human monoclonal antibodies invalid (Kluwer Patent Blog) Southeast Asia: Generic drug market picks up steam in Southeast Asia, finds Front & Sullivan (GenericsWeb) Spain: Commercial Court No 5 of Barcelona: obtaining price for generic medicament an act of… [read post]
21 Nov 2010, 9:02 pm
Bristol-Myers Squibb Co. 2:10-cv-00497; filed November 18, 2010 in the Eastern District of Texas False marking based on BMS' marking of its Cefzil products, its Buspar products, and its Pravachol products U.S. [read post]
17 Nov 2010, 1:48 am
(FDA Law Blog) Crestor (Rosuvastatin) – US: AstraZeneca defeats Teva’s claim that Crestor infringes Teva’s patent (Orange Book Blog) Crestor (Rosuvastatin) – US: AstraZeneca files patent infringement suit against Watson in response to Para IV certification (Patent Docs) Efexor (Venlafaxine) – Australia: Federal Court blocks generic Efexor-XR: Sigma Pharmaceuticals (Australia) Pty Ltd v Wyeth Australia Pty Ltd (Patentology) (BAZPAT) (GenericsWeb) Fipronil – UK:… [read post]
9 Nov 2010, 3:09 pm
The application that led to 5,260,291 took 13 years to allowance. [read post]
9 Nov 2010, 10:33 am
While publication to the scientific community is not the same as disclosure to the PTO and does not foreclose a finding of deceptive intent, see Bristol-Myers Squibb Co. v. [read post]
8 Nov 2010, 7:56 am
Bristol Myers Squibb's potential loss from the information Jhaveri sent in his email was $193,000, Green said. [read post]
4 Nov 2010, 9:59 pm
By James DeGiulio -- Sanofi and BMS Awarded $442M in Plavix Patent Suit Apotex has been ordered to pay $442.2 million in damages to sanofi-aventis and Bristol-Myers Squibb Co. for infringing their patent covering the blood thinner Plavix. [read post]
4 Nov 2010, 6:14 am
”); Bristol-Myers Squibb Co. v. [read post]
2 Nov 2010, 1:40 am
AstraZeneca sought and got a preliminary injunction against Apotex, which was hankering to launch a generic version of the asthma drug Pulmicort. [read post]
27 Oct 2010, 6:45 pm
The Associated Press is reporting that the Food and Drug Administration has "cited drugmaker Bristol-Myers Squibb Co. for multiple deficiencies at its Puerto Rico manufacturing plant, including glass particles in drug vials and possible contamination of sterile drug products. [read post]
27 Oct 2010, 5:45 pm
The Associated Press is reporting that the Food and Drug Administration has "cited drugmaker Bristol-Myers Squibb Co. for multiple deficiencies at its Puerto Rico manufacturing plant, including glass particles in drug vials and possible contamination of sterile drug products. [read post]
11 Oct 2010, 12:59 pm
Since our last post, many more complaints have been filed alleging false marking by various parties in the FDA-regulated industry, including Ranbaxy, Roche Diagnostics Corporation, Walgreens, Bristol-Myers Squibb, Eisai, Takeda, Watson, and many, many others. [read post]
5 Oct 2010, 9:22 pm
., AstraZeneca, Bristol-Myers Squibb, and GlaxoSmithKline - have said that they are being investigated for bribing government officials overseas to gain a larger share of business, the Wall Street Journal reports. [read post]
2 Oct 2010, 8:43 am
Dr. [read post]
